Many of these proteins are encoded on chromosome 5q23-31, including interleukin-3 (IL-3), IL-4, IL-5, IL-9, IL-13, and granulocyte-macrophage colony-stimulating factor (GM-CSF),2" whereas others, such as IL-2 and interferony (IFN-y), are encoded on chromosomes 4 and 6, respecti~ely.6.~ IL-13 was first reported as a cytokine transcript preferentially expressed by murine T-cell clones of the Thz type, ie, producing IL-4 but not IL-2 or IFN-y, and was originally called ~6 0 0 . ' ,~ Although the human IL-4 and IL-13 genes are only about 20% to 30% homologous at the amino acid l e~e l ,~~'~~" they share a striking number of key immunoregulatory effects. Other than IL-4, IL-13 is the only cytokine known that promotes IgE isotype switching by human B cells in the absence of other cytokines." Both IL-13 and IL-4 promote growth and differentiation of normal human B cells and monocytes,"-'7 inhibit cytotoxicity and the production of proinflammatory cytokines by monocytes,''.l6 and increase surface expression of the adhesion molecule vascular cell adhesion molecule-1 (VCAM-1) on endothelial cell^.^*^'^ However, IL-13 and IL-4 also differ in their effects 
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on certain cell types. For example, IL-4, but not IL-13, promotes the growth of human T-cell blasts and clones, a finding that may be explained by the lack of high-affinity IL-13 receptors on T-lineage cells.20-22 Human IL-13 enhances the production of IFN-y from natural killer cells by itself or in conjunction with IL-2 treatment, whereas IL-4 is inhibitory in this situation." IL-13, but not IL-4, synergizes with GM-CSF in promoting colony formation by hematopoietic progenitor cells.23 Thus, although there is considerable overlap in the effects of IL-4 and IL-13, each cytokine may also have a distinct role in regulating T-cell-mediated immune responses.
How IL-13 expression by T cells is controlled at the cellular and molecular level is poorly understood. Previous work has shown that IL-13 mRNA accumulation is induced in peripheral blood CD4 T cells by treatment with anti-CD28 monoclonal antibodies (MoAbs) and phorbol myristate acetate (PMA)." IL-13 and IL-4 mRNA are both expressed at high levels in some murine CD4 Th2-type c10nes'~~ and in a human CD4 T-cell clone of the Tho-type (ie, simultaneously expressing IL-2, IL-4, and IFN-y)," suggesting that both cytokine genes might use common or similar mechanisms for transcription. However, the temporal pattem of IL-13 and IL-4 mRNA expression differ in the lung tissue of mice infected with the Schistsoma m a n s~n i ,~~ indicating that expression of these two cytokine genes can be independently regulated under some conditions in vivo.
Previous physical mapping of the human IL-13 gene by our group4 and others5 has shown that it is located in proximity to the IL-4 and IL-5 genes in the 5q23-31 region. To begin to define the cellular and molecular mechanisms regulating IL-13 gene expression by T cells, we have isolated and sequenced the human IL-13 gene, determined its precise physical location with respect to the IL-4 gene, analyzed its 5' flanking region for potential transcriptional activation elements, and have examined its expression by nontransformed human T-lineage cell populations.
MATERIALS AND METHODS

Isolation and DNA sequence analysis of IL-13 cDNA and genomic
Human IL-13 cDNA fragments, clones 50-1 and 156, were clones.
3316
Blood, isolated using direct selection and were mapped to the region of the human IL-4 and IL-5 genes on chromosome 5 as previously Human chromosome 5-specific cell hybrids,26 IL-4-and IL-5 -containing yeast artificial chromosome^,^' and chromosome 5-specific cosmid?' were analyzed by Southern blotting using these cDNAs as probes. These materials or human genomic DNA were also analyzed by polymerase chain reaction (PCR) using primers derived from clone 50-1 (coding strand primer, S'TGGCGC-TITTG'ITGACCAC; noncoding strand primer, S'ACAGTACAT-GCCAGCTGTCA) and clone 156 (coding strand primer, 5'-CACTGGGCCCCATGGCGCTTT; noncoding strand primer, 5'CGGGATCCTCAGTTGAA-CCGTCC) under standard conditions at an annealing temperature of 50°C. A 6.95-kb BamHI/BamHI fragment of the human IL-13 gene was subcloned from cosmid 58D9 (Fig 1) into the vector pBS (Stratagene, La Jolla, CA) to create clone 10.4 and was sequenced. Genomic or cDNA sequencing was performed for both strands of each clone using T7 Sequenase 2.0 kits following the manufacturer's instructions (US Biochemical, Cleveland, OH). Sequence assembly and analysis were performed using a software package (Intelligenetics, Mountain View, CA). A portion of the DNA sequence obtained has previously been identified as the human IL-13 gene by others.5." Human IL-13 promoter reporter gene constructs and transfection. A 0.98-kb segment of the human IL-13 5' flank region spanning -940 to +48 in relation to the transcription start site was amplified by PCR from the human IL-13 genomic clone 10.2 using the primers S'AGATGGATCCCAGAGACTGGTGAGCAAA (coding strand) and 5'TGTAAAGCTTAGTG-CCAACAGGAGAGGATT (noncoding strand) and Vent polymerase (New England Biolabs, Beverly, MA). To facilitate subcloning BamHI and HindIII restriction sites were included in the 5' region of the coding strand and noncoding strand primers, respectively. The PCR product was gel-purified using Suprec columns following the manufacturer's instructions (Takara, Berkeley, CA), was digested with BamHI and HindIII, and was subcloned into the luciferase reporter gene vector, pGL-2 Basic (Promega, Madison, WI), to create the final plasmid, pIL-I3//uc. PCR by overlap extension" was used to mutate pIL-lS/luc at the P element site at -128 to -11 9 from the sequence GTGGAAAATC to GATATCAATC (the sequence of the noncoding strand is shown, with the mutated residues indicated in bold). The final mutant PCR product was subcloned into pGL-2 basic to create plL-l3mut//uc using the same methods as for the pIL-IS/luc construct. DNA sequencing excluded the presence of any PCR-related errors in the final constructs. The plasmid pCMVlluc (pEQ-176), in which transcription of a luciferase cDNA is driven by the cytomegalovirus (CMV) immediate early gene promoter,3" served as a positive control. Large-scale preparations of these plasmids were prepared using Nucleobond Ax columns (Nest Group, Southboro, MA) following the manufacturer's instructions. For each construct, 10 pg of plasmid DNA was electroporated into 12 X 10' Jurkat thymoma cells (provided by Dr C. Wilson, University of Washington, Seattle, WA) in 0.4 mL of RPMI with 10% fetal calf serum medium using 4-mm electroporation cuvettes and an Electro Cell Manipulator 600 electroporator (BTX, San Diego, CA) at settings of 260 V and 1,050 microfarads. Cells were then diluted to a concentration of 1 X 106/mL in fresh medium and placed at 37°C in a tissue culture incubator for 6 hours. After incubation, aliquots of cells were stimulated with 6.5 pg/mL concanavalin A (Con A; Pharmacia, Piscataway, NJ) and 10 ng/mL PMA (Sigma, St Louis, MO) or were left untreated for an additional 16 hours at 37°C. Where indicated, cyclosporin A (CsA; Sandoz, Basel, Switzerland) was added 1 hour before stimulation at a final concentration of 500 ng/mL. Cells were then harvested by centrifugation, washed in phosphate-buffered saline, dissolved in reporter lysis buffer (Promega, Madison, WI) as directed by the manufacturer, and stored at -80°C until assayed. Lysates were thawed to room temperature, diluted 5-fold in luciferase assay buffer (Promega), and analyzed in duplicate for luciferase activity for 30 seconds using a Monolight 1500 luminometer (Analytical Luminescence Laboratory, San Diego, CA).
Circulating adult and neonatal human T cells were isolated as previously de~crihed.~' To isolate neonatal CD4 T cells or adult CD4 T cells, circulating whole T-cell isolation, priming, and cloning.
For personal use only. on April 16, 2017 . by guest www.bloodjournal.org From mononuclear cells (WMCs) were purified by Ficoll-Hypaque density gradient centrifugation and treated with CD4 Lymphokwik (One Lambda, Los Angeles, CA), a proprietary mixture of complement and MoAbs directed against non-T-lineage and CD8 surface markers, following the manufacturer's instructions. The CD45RA-(CD45ROf) cell subset was purified from adult CD4 T cells using anti-CD45RA MoAb, 3AC532, and an indirect panning technique to deplete CD45RA' cells as previously described." The final purity of each T-lineage cell population was routinely greater than 95% pure based on flow cytometric analysis after staining with appropriate MoAbs. To prime CD4 T cells in vitro, freshly isolated adult CD4 T cells were placed at 1 to 2 X 106/mL into 12-well flat bottom plates (Coming, Coming, NY). Each well contained 1 to 2 x IOh/mL irradiated adult WMCs (30 Gy) in 2 mL of CT.4S medium" supplemented with 3.1 pg/mL of Con A, 0.5 ng/mL of PMA, 5 U/ mL purified human IL-2 (Boehringer-Mannheim, Indianapolis, IN), and 5 ng/mL of recombinant human IL-2 (kindly provided by Dr K. Grabstein, Immunex Corp, Seattle, WA). Overlying medium (0.5 mL) was replaced with an equal volume of fresh CT.4S medium supplemented with 5 U/mL of IL-2 every 3 days. Viable cells were harvested by Ficoll-Hypaque centrifugation after 2 to 3 weeks.
To isolate T-cell clones by direct limiting dilution, purified adult or neonatal CD4 T cells were seeded at 1 or 5 cells per well into 96-well round bottom plates (Coming). Each well contained 100,000 irradiated adult WMCs (30 Gy) in CT.4S medium supplemented with 3.1 pg/mL of Con A, 0.5 ng/mL of PMA, 5 U/mL purified human IL-2, and 5 ng/mL of recombinant human IL-2. Overlying medium (0.1 mL) was replaced with an equal volume of fresh CT.4S medium supplemented with 5 U/mL of IL-2 every 3 to 5 days. After 3 to 4 weeks, growth-positive wells were scored microscopically and expanded in 12-well tissue culture plates by restimulation with Con A, IL-2, and irradiated WMCs every 2 to 3 weeks. Wells with growth after seeding with 5 cells were expanded only if less than 20% of such wells scored positive. Viable clone cells were purified by Ficoll-Hypaque density gradient centrifugation and were extensively washed before use.
Cells were activated at 5 X 106/mL in RPMI medium supplemented with 5% human AB serum as previously described3' using 50 ng/mL PMA in combination with either 25 pg/ mL Con A or 0.5 pmol/L ionomycin (Calbiochem-Behring, San Diego, CA). We used these two activation conditions because they reliably induced high levels of IL-13 "A, whereas other stimuli, such as anti-CD3 MoAb in combination with PMA, were much less effective (data not shown).
Nuclear protein preparations and electrophoretic mobility shift assays (EMSAs). CD4 T cells previously primed in vitro for 2 to 3 weeks were stimulated for 2 hours with Con A (25 ng/mL) and PMA (25 ng/mL), and nuclear proteins were extracted as described by Penix et Nuclear protein extracts (3 to 4 pg) were preincubated at room temperature with buffer (10 mmolL Tris [pH 7.51, 50 mmol/L NaCI, 1 mmovL EDTA, 5% glycerol, 1 mmol/L dithiothreitol, 2 mmolL pefabloc [Boehringer-Mannheim], 2 pg/mL pepstatin A [Calbiochem], and 1 pg of polydI-dC [Pharmacia]) and oligonucleotide competitors for 10 minutes. Probe (2 X lo4 cpm) was then added to a final volume of 25 pL, and the incubation was continued for an additional 15 minutes at room temperature. In some reactions, the nuclear protein was incubated with 1 pL of rabbit antisera raised against the NF-ATp peptide 7234 (QLVPAIPICSIPV-TASLPPLEWPLSNQ) for 30 minutes on ice before the addition of probe. In some cases, the antisera were first incubated with 0.5 pL (500 ng) of either peptide 72 or with, as a negative control, another NF-ATP-derived peptide, peptide 48'4 (SAHELPMVERQDMDS-CLVYGGQQ) for 30 minutes on ice before the addition of nuclear protein. NF-ATP-specific antiserum and peptides were generously provided by Dr A. Rao (Dana Farber Cancer Research Center, Bos-
Cell activation.
ton, MA). All reactions were analyzed by polyacrylamide gel electrophoresis at room temperature using 4% gels in 0.027 molL Trisborate, 0.6 mmoUL EDTA buffer.
Oligonucleotides for EMSAs. Oligonucleotides were synthesized by the Howard Hughes Medical Institute (Seattle, WA). The following double-stranded oligonucleotides were used as probes and unlabeled competitors (in each case, only the noncoding strand is shown): hIL-4 promoter P1 element (-66 to -82 with respect to the transcription start site),35 ATTGGAAATllTCGTTA; mutant hIL-4 promoter PI element, A'ITATAAATTITCGTTA; hIL-13 promoter P element-like site (-134 to -149), TGTGGAAAATCCAGTG; mutant hIL-13 promoter P element-like site, TGTGGTCAATC-CAGTG. Residues that are mutated from the wild-type sequences are indicated in hold. For each probe used in EMSA, complementary oligonucleotide strands were separately end-labeled with y3'P-adenosine triphosphate using T4 kinase and were annealed, and the double-stranded probe was purified by polyacrylamide gel electrophoresis using 10% nondenaturing gels.
RNA blotting and hybridization. Total RNA was isolated by the guanidinium isothiocyanate/CsCl method3' or by the acid guanidinium isothiocyanate -phenol-chloroform extraction method" using a commercial kit (Trireagent; Molecular Research Center, Cincinnati, OH). RNA was blotted, hybridized with "P-labeled RNA or DNA probes, and washed as previously de~cribed.~' The full-length human IL-2, IL-4, and elongation factor-la (EF-la) probes have been de~cribed.~' The human IL-13 cDNA probe was derived fiom a fulllength cDNA clone, p50, and consisted of nucleotides 1 1 to 263." All probes consisted of DNA labeled by the random hexamer priming method" using a commercial lut (Pharmacia), with the exception of the IL-4 probe, for which a single-stranded RNA probe was used."
RESULTS
Organization of human IL-13 and IL-4 genes. We have previously reported the isolation of several human cDNA clones highly homologous to the cytokine encoded by the murine IL-13 (p600) cDNA using a direct selection m e t h~d .~ Using these cDNAs as probes, we isolated two human cosmids that each encompass the IL-13 and IL-4 genetic loci (Fig 1) . Mapping using restriction enzymes showed that the IL-13 and IL-4 genes were separated by about 12 kb. A 6.95-kb BamHI fragment containing the IL-13 gene was subcloned from one of these cosmids, 58D9, and was completely sequenced.* This showed that a CpG island, based on its high G/C content,40 was located 2-kb upstream of the IL-13 transcription start site (Figs 1 and 2) . Based on restriction mapping with rare cutting endonucleases, we did not find evidence of any additional CpG island regions in cosmid 58D9 (data not shown). Our results are consistent with those previously reported for the human IL-13 cDNA" and for a more limited region of the human IL-13 gene.5 The human IL-13 gene had a 4-exon-3-intron structure found in the IL-4 gene and most other T-cell-derived cytokines (Fig 1) . In agreement with the results of others,','' we found that the predicted 3' untranslated region of IL-13 mRNA contained multiple AUUA sequences (data not shown) that have been observed in all T-cell-derived cytokine genes to date and appear to confer mRNA instability!' Our analysis also showed that the human IL-13 and IL-4 genes are in the same * This sequence is available via Genebank Accession No. U31120.
For personal use only. on April 16, 2017 . by guest www.bloodjournal.org From 
BamHI w -2159 G G A T C C C C a C T a A C A A T C C A G A C C C T C T G A T G T A G C C A T C T G T G C C G C G C C T C T C m C C G C C C G C
-
-1359 CTTCGAGTGTGGACAGAGAGGGTGGGAATGACGTTCCCTGTGGGAAGAGAGGGTGGGCAAGCCTGGGATGCCTCTGAGCG -1279 G G A A T C C A G C A T O C C T T G T G A G G A G G G T C A C A A G C
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AGAAAGACCTCTGAATCTTTCT~ATCTCTCAGTGGAGAACCTGG~TCTGAACTTTGACAATCCCTCTCACAGTGGG
GGCCAAGGAGGAATTAGGC~GCC~GAAGTGAACTTTACTCTTCTATTGCCTGTTTGAATTTTG~ATCCAAGCAAGT
GTTACTTAAGTAATTTAAGAGACTGGTTCATCG~T~CTCCCC~TTCCCATAGC~GGTAGACTGTGGTCAC
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GTGCCTGAAAAAGCAGAGACCATGGTGTCAGGCGTCACCACTTGGGCCTAT~GCTGCCACAAGACGCCAA~CCACA
AAGCCACCCAGCCTATGCATCCGCTCCTCAATCCTCTCCTGTTGGCACTGGGCCTCAT~
The 5' flanking region of the human IL-13 gene. The CpG island region located between -2159 t o -718 is indicated in bold. A purine-****** rich sequence lnoncoding strand) at -129 to -122 with homology to 11-4 promoter P element sequences is in bold and underlined. A TATA box is indicatod by overlying asterisks. The presumed transcription start site, assigned +1, and the initiator codon a t +56, indicated in italics, have been previously reported by others.'," transcriptional orientation. Whether the few discrepancies of our sequence that differ from those previously published for the human E-13 cDNA" and gene5 represent polymorphisms remains to be determined. Our sequence was determined independently for both strands and, therefore, is unlikely to contain sequencing errors. 
DOLGANOV ET AL
Previous work by others has identified a purine-rich sequence, termed the P element, in the 5' flank region of the murine and human IL-4 genes that is critical for their trans~ription.~'-~' P elements bind proteins of the NF-AT transcription factor family in vitr0.4'-~' An analysis of the human IL-13 gene's 5' flank region showed a purine-rich sequence similar to that of the human IL-4 P element, PI (see legend to Fig 2) . To test the functional importance of this putative P element, we first established that a segment of the IL-13 5' flank region, from -940 to +48, was sufficient to confer transcription of a reporter gene in response to T-cell activation using the construct plL-I3/luc. We found that Jurkat thymoma cells constitutively expressed low amounts of IL-13 transcripts that increased approximately 5-to IO-fold after stimulation with Con A and PMA (data not shown). We used this cell line to test the activity of IL-13 promoter constructs in response to T-cell activation. Promoter activity of plL-I3/luc in unstimulated Jurkat cells was similar to the background levels of those observed with a promoterless luciferase plasmid, pGL-2 (Fig 3) . After activation with Con A and PMA, IL-13 promoter activity increased approximately 100-to 300-fold above the levels observed in unstimulated cells. Under these conditions, the activity of the CMV immediate early gene promoter, a strong and constitutively active promoter, increased only about 5-fold in response to stimulation. This suggested that the marked increase in IL-I3 promoter activity in response to stimulation was not merely because of cell activation increasing the proportion of cells containing reporter plasmids at the time of harvest. IL-13 expression by T cells is inhibited by CsA;" and a variety of evidence suggests that NF-AT transcriptional activator proteins are major targets for the inhibition of cytokine gene transcription by CsA.'" Treatment of Jurkat cells with CsA reduced the increase in reporter gene activity of pIL-I3/luc after Con A and PMA treatment by approximately 80% (Fig 3) . A construct containing a 5-bp substitution mutation of the IL-13 promoter P element (pIL-13mut/ luc) also reduced promoter activity in stimulated Jurkat T cells by approximately 80%. This construct was mutated in the GGAA residues that others have shown to be critical for transcriptional activation by IL-4 P elements and for binding of NF-AT protein^."'.^' These results suggest that the P element is essential for transcription of the IL-13 gene in response to T-cell activation, and that the CsA-sensitive NF-AT family of proteins are likely candidates for mediating transcriptional activation via this element. CsA treatment of stimulated Jurkat cells transfected with pIL-l3mut/luc reduced residual promoter activity by approximately 50%, as compared with that obtained with stimulated Jurkat cells and plL-l3mut//uc without CsA. Thus, a portion of IL-13 promoter activity may be mediated by CsA-resistant transcription factors.
The IL-I3 P element binds the transcriptional activator protein NF-ATp. Using EMSA, we compared oligonucleotides containing either the putative IL-13 P element or the human IL-4 PI element for their binding of nuclear proteins contained in activated T cells. Adult human CD4 T cells that had previously been primed in vitro, a cell population that expresses high levels of IL-4" and IL-13 transcripts (data not shown), was used as a source of nuclear protein.
As shown in Fig 4A , and in agreement with previous work by others: a radiolabeled probe for the human IL-4 gene P element, PI, formed a complex with nuclear protein purified from this CD4 T-cell population. This complex was specific in that it was effectively competed with an unlabeled IL-4 promoter oligonucleotide but not by an IL-4 PI mutant oligonucleotide. The oligonucleotide containing the P-element-like sequence from the human IL-13 promoter effectively competed with the human IL-4 PI probe for specific protein binding (Fig 4A, lane 4) . This competition was specific in that the mutation of two adjacent residues in the IL-I3 oligonucleotide ablated this competition (Fig 4A, lane 5) . When the human IL-13 promoter oligonucleotide, itself, was used as a probe, a complex was formed with mobility similar to that observed with the human IL-4 probe (Fig 4B, I). This complex was specific in that it was efficiently competed by unlabeled 1L-13 oligonucleotide but not by an IL-13 mutant oligonucleotide. The human IL-4 PI element oligonucleotide was also an effective competitor for protein binding to the IL-13 probe. Furthermore, the mutant IL-4 PI oligonucleotide that was ineffective in blocking nuclear protein complex formation with the IL-4 PI element (Fig  4B, lane 3) was also ineffective in competition with the IL-13 probe. The majority of the IL-13 oligonucleotide-protein complex was efficiently supershifted by NF-ATP antiserum (Fig 4B, lane 6) , as was the complex formed with the human IL-4 PI probe (data not shown). Inclusion of the specific NF-ATp peptide to which the antiserum was raised prevented this supershift (lane 7), whereas inclusion of an equal amount of irrelevant peptide did not (lane 8). Therefore, the IL-4 PI and IL-13 P element oligonucleotides had similar or identical binding specificity for nuclear proteins from activated CD4 T cells that had been primed in vitro. We also observed this NF-ATP-containing complex with the IL-13 or IL-4 P element oligonucleotides when freshly-isolated adult CD4 T cells that had been polyclonally activated for 2 hours were used as a source of nuclear protein. However, the amount of complex under these conditions was only about one tenth that observed when primed CD4 T-cell protein extracts were used with either the IL-4'* or the 1L-13 P element probes (data not shown). Together, these results show a striking correlation between the abundance of nuclear protein binding to the human IL-13 and human IL-4 P elements and the capacity of T cells to express the IL-13 and IL-4 genes. In addition, a major component of nuclear protein binding to these P elements in activated adult CD4 T cells was NF-ATP.
IL-13 mRNA expression by humon T-cell populotions. To gain insight into the cellular mechanisms regulating IL-13 gene expression, we compared IL-13, IL-4, and IL-2 mRNA expression by a variety of normal human T-cell populations after polyclonal activation. We first examined the kinetics of IL-13 transcript expression by circulating freshly isolated adult human T cells (Fig 5, lanes 1-4) . IL-13 transcripts were undetectable in unstimulated cells but were observed after activation with Con A and PMA, with peak levels achieved at approximately 6 hours of incubation. The kinetics of IL-2 and IL-4 mRNA accumulation after activation was similar to that observed for IL-I 3 transcripts. Levels of transcripts for all three cytokines were typically low to For personal use only. on April 16, 2017 . by guest www.bloodjournal.org From undetectable at 24 hours of incubation. The amount of transcripts for EF-1 a, an abundant "housekeeping" gene product involved in protein translation," was similar in all lanes, indicating that the differences in cytokine mRNA levels observed at different time points were not caused by differences in the amount of total RNA loaded per lane. Similar kinetics of cytokine mRNA accumulation were also observed for the IL-13, IL-4, and IL-2 genes when adult T cells were stimulated with the combination of ionomycin and PMA (data not shown).
Circulating CD4 T cells from healthy adults are comprised of two mutually exclusive subsets identified by their reciprocal surface expression of the CD4SRA and CD4SRO isoforms of the CD4S protein tyrosine phosphatase m o l e c~l e .~~~'~ To determine if IL-I 3 was differentially expressed by CD4 T cells based on their surface expression of CD4S isoforms, cytokine mRNA expression by the CD45RA-(CD4SRO') and unfractionated CD4 T cells were compared after their activation in vitro. CD4SRA-CD4 T cells were highly enriched in IL-13 mRNA as compared with unfractionated CD4 T cells (Fig 5 , lane S v lane 6 ). In agreement with previous results,'x an enrichment for IL-4 mRNA expression by CD4SRATD4 T cells was also observed. Depending on the donor used, IL-2 mRNA levels in CD4SRA-CD4 T cells ranged from being substantially lower (Fig 5 ) or similar to that in unfractionated CD4 T cells". In contrast, the enrichment for IL-4 and IL-13 mRNA expression by CD4SRA-CD4 T cells as compared with that by unfractionated CD4 T cells was consistent in all four blood donors we examined (data not shown).
A variety of evidence suggests that circulating CD45RO' T cells represent a population that has previously been activated or "primed" in vivo by antigen.".'4.'" Taken together with the results above, this suggests that priming of T cells preferentially upregulates IL-13 but not IL-2 gene expression. Two predictions of this model are that (1) IL-13 mRNA expression should be low to undetectable in T-cell populations that have had limited exposure to antigens, such as neonatal T cells, and (2) priming of these antigenically naive populations by repetitive activation in vitro should upregulate expression of the IL-13 gene but not of the IL-2 gene. To test these predictions, freshly-isolated neonatal T cells, adult T cells, and several clones derived from neonatal CD4 T cells or adult CD4 T cells were compared for their expression of IL-13. IL-4. and IL-2 mRNA after activation in vitro. IL-13 was undetectable in freshly isolated neonatal T cells, whereas adult T cells routinely contained substantial levels of IL-13 transcripts under these conditions (Fig 6) . In agreement with previous published results,3x the pattern of IL-4 mRNA expression by neonatal T cells was, similar to IL-13 mRNA expression, low to undetectable, whereas, in contrast, the level of IL-2 transcripts in neonatal T cells was similar to that in adult T cells. These selective deficits in cytokine expression by neonatal T cells as compared with that by adult T cells were observed after activation with either Con A and PMA or with ionomycin and PMA (data not shown). Unlike freshly isolated cells, neonatal CD4 T cells propagated in vitro as clones expressed high levels of IL-13 and IL-4 transcripts (Fig 6) . In contrast. IL-2 gene expression by individual clones was either similar, or only modestly increased, as compared with that found in freshlyisolated cells. These neonatal clones were of the Tho type in that they also expressed significant amounts of IFN-y mRNA (data not shown). We also observed marked increases in the expression of the IL-13 and IL-4 genes, but not of the IL-2 gene, in neonatal or adult CD4 T cells that were primed in vitro in bulk for IO to 14 days and were then restimulated (data not shown).
DISCUSSION
We and others have shown physical linkage for at least five cytokine genes in 5q23-3 1 ,2-5.'7 including IL-I 3, IL-4, IL-5, IL-3, GM-CSF, and IL-9. This close physical linkage is also confirmed by synteny studies in mice that indicate that these cytokines map to mouse chromosome I 1 .' A comparison of the different chromosome 5 cytokine genes with each other shows similar exon sizes and exon-intron structure, some limited DNA sequence homology in their 5' flank regulatory regions, and some limited amino acid homology in their N-and C-terminal regions.' However, with the exception of the IL-4 and IL-13 genes, most of the coding sequences of this cytokine cluster show little sequence homology with one another. Therefore, these genes, as a group, do not appear to be clustered because of recent gene duplicaFor personal use only. on April 16, 2017 . by guest www.bloodjournal.org From tion events. Although it is unclear why all of these cytokine genes have remained clustered during evolution, the contiguity of the IL-3 and GM-CSF genes (10 kb apart in the human and 14 kb apart in the mouse) may be explained by their sharing an enhancer segment located between the two gene^.'^.^^ The fact that the human IL-13 and IL-4 genes are located a similar distance apart (12 kb) raises the possibility that these two cytokine genes might also share an enhancer element.
The finding of a CpG island 2 kb upstream from the human IL-13 gene is unexpected in that CpG islands have not been previously observed in the regions flanking the genes that encode other T-cell-derived cytokines, including IL-2, IL-4, IL-5, IL-6, GM-CSF, and IFN-y6'. CpG islands have been implicated in maintenance of an open chromatin configuration that may facilitate gene transcription.6' Further studies will be required to establish that the CpG island proximal to the IL-13 and IL-4 genetic loci influence their transcriptional activation in vivo.
The contiguity of the IL-4 and IL-13 genes that we have shown here, their significant genetic homology," and, based on an analysis of murine CD4 T-cell clones, their tendency to be coordinately e x p r e~s e d~,~ suggested that the promoters of these cytokines genes might use similar cis-regulatory elements. Although we only found about 20% sequence homology between the IL-13 and IL-4 promoter regions over the first 2 kb 5' of the transcription start site (data not shown), we identified a purine-rich sequence in the IL-13 promoter homologous to the P elements of the IL-4 gene. Our results using transiently transfected reporter gene constructs show that this element significantly contributes to IL-13 promoter activity in response to T-cell activation. We found that this IL-13 P element was similar to the IL-4 promoter P1 element in specifically binding in vitro the transcription activator protein, NF-ATP. In addition, we have found a striking direct correlation in normal human T-lineage cell populations between the amount of NF-ATp in the nucleus after activation and the capacity of T cells to express IL-452 and IL-13 mRNA (D. Lewis and S. Bort, manuscript in preparation). NF-AT protein translocation from the cytoplasm to nucleus in response to T-cell activation is inhibited by CsAS0. Therefore, our finding that IL-13 promoter activity in response to stimulation was markedly inhibited by CsA supports the idea that NF-AT proteins may play a role in IL-13 transcription by T cells in vivo. Together, our results are consistent with a model in which the availability of NF-ATP for binding to these two cytokine genes could be an important determinant of the efficiency with which they are transcribed. In a number of T-cell-derived cytokine promoters, including that for the IL-4 gene, NF-AT-binding P elements have been shown to interact with adjacent AP-1 binding sites in activating trans~ription.~~'~ Whether this is true for the P element site of the IL-13 gene that we have identified remains to be determined.
Our finding that a modest portion of IL-13 promoter activity persisted in Jurkat cells treated with CsA and transfected with an IL-13 promoter construct in which the P element site was mutated is consistent with a role for transcription factors other than NF-AT proteins in directing IL-13 gene transcription. A number of other transcription factors besides NF-ATp and AP-1, including HMG-1, NF-Y, and octamer proteins, have been reported to bind to cis-elements in the IL-4 5' flank r e g i~n~~.~' and, therefore, are candidates to regulate IL-4 gene transcription. Because there are potential binding sites for these and other DNA binding proteins in the human IL-13 5' flank region (data not shown), it will be of interest to determine if these proteins also play a role in the transcriptional regulation of the IL-13 gene.
We found that the human IL-13 and IL-4 genes were coordinately expressed by various human T-cell populations, both in bulk and at the clonal level, but the molecular mechanisms by which this is achieved remain unclear. The temporal patterns of IL-13, IL-4, and IL-2 mRNA accumulation after T-cell activation were similar, with peak levels achieved for all three cytokine transcripts at approximately 6 hours of incubation. By 24 hours of incubation, transcript levels for all three cytokine genes were very low to undetectable. These results differ from those of Zurawski and de Vries" who reported that human T-cell clones activated in vitro had detectable IL-13 mRNA levels for up to 72 hours after activation, long after IL-4 mRNA had decreased to undetectable levels. Whether these differences reflect the particular T-cell populations studied (freshly isolated T cells versus clones) or the stimulus used for activation remains to be determined. Based on studies of IL-2 gene expression by T cells,6' it is likely that the transient wave of IL-13 and IL-4 mRNA accumulation that we observed after activation in vitro is cause, in part, by the relatively short period during which these cytokine genes are transcribed (D. Lewis, unpublished observations). In addition, the transient accumulation of IL-13 may also be explained by the fact that the IL-13 transcript, similar to those for IL-463 and IL-2,@ contains AUUUA sequences in the 3' untranslated region that appear to decrease mRNA ~tability.~'
The current study also shows that expression of the IL-13 and IL-2 genes in freshly isolated human T cells is independently modulated. Among adult CD4 T cells, the CD45RA-(CD45RO+) subset was highly enriched in the capacity to express IL-13 mRNA and, in agreement with results of earlier results,38 IL-4 mRNA, whereas the expression of IL-2 transcripts was not enhanced. The CD45RA' and CD45RO' subsets comprise approximately 60% and 40%, respectively, of circulating adult CD4 T ~e l l s . '~.~~ The CD45RO+ subset is highly enriched in functional memory T cells, defined by their enhanced responses to recall antigen~.'~.'~ These enhanced responses are presumed to be a result of previous activation and expansion of this cell population in vivo in response to cognate CD45RA+ cells may serve as the precursors of the primed CD45RO+ population, although this remains a point of controver~y.'~ Our findings suggest that the IL-13 gene and IL-4 genes are similar in that priming of T cells in vivo appears to upregulate their capacity to express these two cytokines but does not enhance IL-2 gene expression.
The lack of detectable IL-13 or IL-4 mRNA expression by neonatal T cells, a cell population that presumably has had insignificant exposure to foreign antigen, is also consistent with a model in which high levels of IL-13 and IL-4
For personal use only. on April 16, 2017 . by guest www.bloodjournal.org From gene expression depend on previous T-cell activation in vivo. The surface phenotype of neonatal T cells is greater than 95% CD45RA+CD45RO-,55 again suggesting that this pattern of surface expression of CD45 isoforms identifies Tcell populations that are antigenically naive. Because IL-2 expression by neonatal T cells was similar to or greater than that by adult T cells, the low level of IL-13 mRNA expression by this cell type cannot be attributed to a global immaturity in its capacity to produce cytokines. In addition, the observation that neonatal CD4 T-cell clones were routinely able to express high levels of IL-13 and IL-4 mRNA suggests that neonatal CD4 T cells are not intrinsically limited in their capacity to express these cytokines and, under suitable conditions of priming in vitro and, presumably, in vivo, can acquire the capacity to express both IL-13 and IL-4 at high levels similar to those found in adult CD4 T-cell clones. The markedly higher levels of IL-13 and IL-4 mRNA in adult CD4 T-cell clones compared with those in freshly isolated adult T cells suggests that priming in vitro is also a potent inducer in this cell population for an increased capacity to express these cytokines. This priming model is supported by studies showing that, when circulating neonatal T cells or adult CD45RA+CD4 T cells are propagated in bulk for short periods of time in vitro, their capacity to express IL-4 mRNA is increased, whereas IL-2 gene expression remains unIn summary, we have found that the IL-13 and IL-4 genes are located a short distance apart, increasing the possibility that these two cytokines may share common regulatory regions, such as an enhancer. It is plausible that additional coregulated cytokine genes may reside in this already cytokine-rich region of the human genome. The IL-13 and IL-4 promoters appear to both use NF-AT-binding P elements for their transcriptional activation in response to T-cell activation. Our results using untransformed human T-cell populations support the results of earlier studies of murine CD4 T-cell c10nes~~~ showing that the IL-13 and IL-4 genes tend to be coordinately expressed after T-cell activation and indicate that prior activation, ie, priming, is required for either of these cytokines to be expressed at high levels by T cells. Because NF-ATP binding activity to P elements is higher in primed T cells than that in freshly isolated T cells, the IL-13 and IL-4 P elements could mediate, at least in part, the coordinate expression of these two cytokines in activated T cells.
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